Resverlogix (TSX:RVX) Tax Rate % : -0.06% (As of Sep. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Resverlogix Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Resverlogix's Tax Expense for the three months ended in Sep. 2024 was C$0.00 Mil. Resverlogix's Pre-Tax Income for the three months ended in Sep. 2024 was C$-6.68 Mil. Therefore, Resverlogix's Tax Rate % for the quarter that ended in Sep. 2024 was -0.06%.

Resverlogix Tax Rate % Historical Data

The historical data trend for Resverlogix's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix Tax Rate % Chart

Resverlogix Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Dec21

Dec22

Dec23

Tax Rate %

Get a 7-Day Free Trial

-0.02

0.02

-0.05

-0.49

-0.09

Resverlogix Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Rate %	Get a 7-Day Free Trial															-0.07	-0.17	0.22	-0.05	-0.06

Resverlogix Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Resverlogix's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2023 )	/	Pre-Tax Income (A: Dec. 2023 )
	=	0.02	/	-22.44
	=	-0.09 %

Resverlogix's Tax Rate % for the quarter that ended in Sep. 2024 is calculated as

Tax Rate %	=	Tax Expense (Q: Sep. 2024 )	/	Pre-Tax Income (Q: Sep. 2024 )
	=	0.004	/	-6.681
	=	-0.06 %

Resverlogix Tax Rate % Related Terms

Thank you for viewing the detailed overview of Resverlogix's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Resverlogix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (TSX:RVX) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

RVXCF:USA 0VF9:UK RFS:Germany

Address

4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1

Website

https://www.resverlogix.com

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

Executives

Aaron Bradley Cann	Senior Officer
Kenneth Eugene Lebioda	Senior Officer
Dr. Jan Ove Johansson	Senior Officer

Resverlogix Headlines

No Headlines